Precipio, Inc. (PRPO)

USD 5.56

(-3.81%)

Total Debt Summary of Precipio, Inc.

  • Precipio, Inc.'s latest annual total debt in 2023 was 1.11 Million USD , down -19.83% from previous year.
  • Precipio, Inc.'s latest quarterly total debt in 2024 Q1 was 933 Thousand USD , down -16.4% from previous quarter.
  • Precipio, Inc. reported annual total debt of 1.39 Million USD in 2022, down -2.66% from previous year.
  • Precipio, Inc. reported annual total debt of 1.43 Million USD in 2021, down -4.09% from previous year.
  • Precipio, Inc. reported quarterly total debt of 1.17 Million USD for 2024 Q2, up 25.4% from previous quarter.
  • Precipio, Inc. reported quarterly total debt of 1.29 Million USD for 2023 Q3, up 21.46% from previous quarter.

Annual Total Debt Chart of Precipio, Inc. (2023 - 1999)

Historical Annual Total Debt of Precipio, Inc. (2023 - 1999)

Year Total Debt Total Debt Growth
2023 1.11 Million USD -19.83%
2022 1.39 Million USD -2.66%
2021 1.43 Million USD -4.09%
2020 1.49 Million USD 9.79%
2019 1.35 Million USD -73.4%
2018 5.1 Million USD 42.64%
2017 3.57 Million USD -54.2%
2016 7.81 Million USD 2.87%
2015 7.59 Million USD 3.0%
2014 7.37 Million USD 44.47%
2013 5.1 Million USD -17.27%
2012 6.17 Million USD -48.75%
2011 12.04 Million USD 22.89%
2010 9.79 Million USD 116.7%
2009 4.52 Million USD -16.03%
2008 5.38 Million USD 5.69%
2007 5.09 Million USD -21.92%
2006 6.52 Million USD -13.48%
2005 7.54 Million USD -20.93%
2004 9.53 Million USD 148.71%
2003 3.83 Million USD 145.52%
2002 1.56 Million USD 0.0%
2001 - USD 0.0%
2000 - USD -100.0%
1999 17.45 Million USD 0.0%

Peer Total Debt Comparison of Precipio, Inc.

Name Total Debt Total Debt Difference
Bionano Genomics, Inc. 87.94 Million USD 98.731%
Prenetics Global Limited 2.36 Million USD 52.899%
Star Equity Holdings, Inc. 3.6 Million USD 69.077%
CareDx, Inc 34.22 Million USD 96.739%
Exact Sciences Corporation 2.55 Billion USD 99.956%
Exagen Inc. 23.72 Million USD 95.295%
Inotiv, Inc. 417.64 Million USD 99.733%
Guardant Health, Inc. 1.35 Billion USD 99.918%
Biodesix, Inc. 60.69 Million USD 98.161%
BioNexus Gene Lab Corp. 133.39 Thousand USD -736.613%
iSpecimen Inc. 196.24 Thousand USD -468.68%
Natera, Inc. 441.99 Million USD 99.748%
Aspira Women's Health Inc. 2.26 Million USD 50.75%
Standard BioTools Inc. 98.21 Million USD 98.864%
23andMe Holding Co. 76.51 Million USD 98.541%
Castle Biosciences, Inc. 15.31 Million USD 92.711%
Personalis, Inc. 48.96 Million USD 97.721%
Aclaris Therapeutics, Inc. 426 Thousand USD -161.972%
Applied DNA Sciences, Inc. 1.23 Million USD 9.837%
OpGen, Inc. 13.04 Million USD 91.444%
T2 Biosystems, Inc. 49.49 Million USD 97.745%
Myriad Genetics, Inc. 145 Million USD 99.23%
ICON Public Limited Company 3.93 Billion USD 99.972%
NeoGenomics, Inc. 611.67 Million USD 99.818%
Star Equity Holdings, Inc. 3.6 Million USD 69.077%
IDEXX Laboratories, Inc. 947.88 Million USD 99.882%
RadNet, Inc. 1.49 Billion USD 99.925%
MDxHealth SA 41.26 Million USD 97.296%
Psychemedics Corporation 2.29 Million USD 51.436%
Illumina, Inc. 2.26 Billion USD 99.951%
Check-Cap Ltd. - USD -Infinity%
Twist Bioscience Corporation 94.06 Million USD 98.814%
DarioHealth Corp. 29.54 Million USD 96.222%
Fulgent Genetics, Inc. 14.9 Million USD 92.514%
Sera Prognostics, Inc. 1.85 Million USD 39.935%
ENDRA Life Sciences Inc. 394.4 Thousand USD -182.959%
OPKO Health, Inc. 326.56 Million USD 99.658%
Medpace Holdings, Inc. 142.12 Million USD 99.215%
Neogen Corporation 906.23 Million USD 99.877%
Intelligent Bio Solutions Inc. 871.44 Thousand USD -28.064%
Prenetics Global Limited 2.36 Million USD 52.899%
Mainz Biomed B.V. 7.42 Million USD 84.961%
bioAffinity Technologies, Inc. 1.57 Million USD 29.306%
Trinity Biotech plc 67.42 Million USD 98.345%
Neuronetics, Inc. 62.47 Million USD 98.214%
Sotera Health Company 2.32 Billion USD 99.952%
bioAffinity Technologies, Inc. 1.57 Million USD 29.306%